InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by ANDREA ELLIS. Director active across 1 company, notably BridgeBio Pharma, Inc.. In total, 1 reports have been published. History available since 9 July 2026. The latest transaction was disclosed on 9 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration